| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |